Atlas Trials

A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

Clinical trial NCT03196375 · TERMINATED

Trial details

NCT number
NCT03196375
Sponsor
Flex Pharma, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Motor Neuron Disease
Start date
2017-07-28
Primary completion
2018-07-27
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.